Legato Biologics’ SparxNano™ technology is a cutting-edge platform designed to rapidly identify high-affinity, highly selective nanobodies targeting specified extracellular proteins within just four months. This accelerated timeline allows for faster therapeutic development, providing a competitive edge in the biologics landscape. Leveraging advanced discovery techniques and proprietary processes, SparxNano™ ensures precise target engagement and exceptional specificity, making it an ideal solution for challenging therapeutic targets.
The platform harnesses the unique advantages of nanobody technology, such as their small size, high stability, and strong binding affinity, to address complex biological challenges. Unlike conventional monoclonal antibodies, nanobodies developed through SparxNano™ exhibit superior tissue penetration and robust performance in diverse applications, including oncology, autoimmune diseases, and targeted drug delivery. The technology identifies and optimizes nanobody candidates with enhanced binding and physiochemical properties, meeting the rigorous demands of therapeutic and diagnostic applications.
SparxNano™ provides a seamless, end-to-end development process, from target selection and library screening to lead optimization and characterization. Our proprietary platform employs advanced screening strategies and bioinformatics-driven selection methods to identify the most promising candidates promptly and efficiently. With a focus on extracellular protein targets, SparxNano™ offers a highly tailored approach, allowing partners to advance their therapeutic programs with confidence and speed.
By integrating efficiency, precision, and innovation, SparxNano™ empowers our partners to accelerate their biologics pipelines and achieve significant milestones in short timeframes. With a proven track record of delivering high-quality nanobody candidates, Legato Biologics stands as a trusted partner for companies seeking to harness the power of nanobody therapeutics for groundbreaking medical innovations.
